Corcept has reached a preliminary settlement of all claims in the purported securities class action against Corcept and certain of its executive officers captioned Melucci v. Corcept Therapeutics Incorporated, et al., Case No. 5:19-cv-01372-LHK, which was pending in the United States District Court for the Northern District of California.
Corcept Therapeutics To Pay $14M On Proposed Settlement Of Purported Securities Class Action
Corcept has reached a preliminary settlement of all claims in the purported securities class action against Corcept and certain of its executive officers captioned Melucci v. Corcept Therapeutics Incorporated,
Related Posts
HC Wainwright & Co. Initiates Coverage On Tango Therapeutics with Buy Rating, Announces Price Target of $10
HC Wainwright & Co. analyst Robert Burns initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Buy rating and announces Price Target of $10.
Raymond James Maintains Outperform on Broadridge Financial Soln, Lowers Price Target to $181
Raymond James analyst Patrick O'Shaughnessy maintains Broadridge Financial Soln (NYSE:BR) with a Outperform and lowers the price target from $192 to $181.